New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2013
10:13 EDTAEGN, VCI, ARII, SXC, UAL, RGC, BPL, XEC, WRI, YHOO, CBI, SXE, CCE, ABBV, CGO, GIS, INTC, RPT, PDM, SUSQ, CSE, ARROn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ARMOUR Residential (ARR) downgraded to Equal Weight from Overweight at Barclays... AbbVie (ABBV) downgraded to Market Perform from Outperform at BMO Capital... Buckeye Partners (BPL) downgraded to Hold from Buy at Deutsche Bank... CapitalSource (CSE) downgraded to Equal Weight from Overweight at Barclays... Coca-Cola Enterprises (CCE) downgraded to Neutral from Buy at Goldman... Regal Entertainment (RGC) downgraded to Neutral from Buy at MKM Partners... Southcross Energy Partners (SXE) downgraded to Equal Weight at Barclays... Susquehanna (SUSQ) downgraded to Hold from Buy at Jefferies... United Continental (UAL) downgraded to Equal Weight from Overweight at Evercore... Piedmont Office Realty (PDM) downgraded to Sell from Hold at Stifel... Chicago Bridge & Iron (CBI) downgraded to Overweight from Focus List at Johnson Rice... SunCoke Energy (SXC) downgraded to Buy from Conviction Buy at Goldman... Ramco-Gershenson (RPT) downgraded to Underperform from Neutral at BofA/Merrill... Yahoo (YHOO) downgraded to Hold from Buy at Pivotal Research... American Railcar (ARII) downgraded to Equal Weight from Overweight at Stephens... Intel (INTC) downgraded to Market Perform from Outperform at JMP Securities... Weingarten Realty (WRI) downgraded to Neutral from Buy at BofA/Merrill... Valassis (VCI) downgraded to Neutral from Buy at Lazard Capital... General Mills (GIS) downgraded to Equal Weight from Overweight at Morgan Stanley... Range Resources (RRC) downgraded to Neutral from Accumulate at Global Hunter... Aegion (AEGN) downgraded to Underperform from Neutral at Wedbush... Cabot Oil & Gas (COG) downgraded to Neutral from Accumulate at Global Hunter... Cimarex Energy (XEC) downgraded to Neutral from Buy at Global Hunter.
News For ARR;ABBV;BPL;CSE;CCE;RGC;SUSQ;SXE;UAL;PDM;CBI;SXC;RPT;YHOO;ARII;INTC;WRI;VCI;GIS;XEC;AEGN;CGO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 >>
January 28, 2016
08:33 EDTYHOOOptions expected to be active
Subscribe for More Information
07:12 EDTABBVAbbVie intiates enrollment in Phase 3 clinical program for Elagolix
AbbVie (ABBV), in cooperation with Neurocrine Biosciences (NBIX), announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo. These studies are designed to assess the change in menstrual blood loss utilizing the alkaline hematin method, comparing baseline to month six of treatment. Additional secondary efficacy endpoints are being evaluated; including assessing changes in fibroid volume, monthly blood loss and hemoglobin levels. Bone mineral density will also be assessed.
07:00 EDTSXCSunCoke Energy sees FY16 domestic coke production 4.1M tons
Subscribe for More Information
06:59 EDTSXCSunCoke Energy reports Q4 EPS 30c, may not compare t consensus 4c
Subscribe for More Information
06:56 EDTYHOOVerizon denies report of bidding on Yahoo core business, CTFN says
Verizon (VZ) spokesperson for Bob Varettoni said the New York Post "was wrong" in reporting on January 23 that the telecom company made an offer to acquire Yahoo's (YHOO) Internet search business, reported CTFN. Varettoni told the publication: "The rumor's false...We've made no offer to acquire Yahoo." Reference Link
06:30 EDTYHOOYahoo starts restructuring with 'invest/maintain/kill' list, Re/code reports
Subscribe for More Information
06:17 EDTYHOOYahoo starts restructuring with 'invest/maintain/kill' list, Re/code reports
Subscribe for More Information
05:54 EDTABBVStocks with implied volatility movement; EMR ABBV
Stocks with implied volatility movement; Emerson (EMR) 38, AbbVie (ABBV) 42 according to iVolatility.
05:44 EDTYHOOSpringOwl calls for Yahoo, Viacom to seek partners, Reuters reports
SpringOwl Asset Management, which holds undisclosed stakes in Yahoo (YHOO) and Viacom (VIA), is urging the boards of both companies to seek investments from strategic partner, Reuters reports, citing an article that is set to be published today. SpringOwl managing director Eric Jackson says that "Although some shareholders of both Yahoo and Viacom think that a simple sale or break-up of both companies is the best way to create value for shareholders, we believe that both companies could benefit from their own version of the 'Buffett Convert,'" and that while stakes of investors would be diluted if an outside investor steps in, but "they would still be better off because their shares would likely get re-rated upwards substantially with this new partner sitting around the board table." Jackson believes Yahoo should seek outside investment from Liberty Media (LMCA), Verizon (VZ) or AT&T (T), while Viacom would benefit from Alibaba (BABA), Amazon (AMZN) or AMC Entertainment (AMC). Reference Link
05:37 EDTABBVAbbVie announces venetoclax granted Breakthrough Therapy Designation by FDA
Subscribe for More Information
January 27, 2016
12:19 EDTABBVPiper Jaffray biopharma analyst holds an analyst/industry conference call
Subscribe for More Information
11:07 EDTABBVGilead sinks as Attorney General probes pricing strategy
Shares of drugmaker Gilead (GILD) are underperforming after Massachusetts Attorney General Maura Healey warned that her office may bring an unfair commercial conduct complaint against it related to the pricing for its Hepatitis C virus treatments Sovaldi and Harvoni. UNFAIR PRICING: Healey, in a letter addressed to Gilead CEO John Martin dated January 22 that has just been made public, said that her office is considering whether Gilead's pricing strategy for Sovaldi and Harvoni may constitute an "unfair trade practice" in violation of Massachusetts law. "Because Gilead's drugs offer a cure for a serious and life-threatening infectious disease, pricing the treatment in a manner that effectively allows HCV to continue spreading through vulnerable populations, as opposed to eradicating the disease altogether, results in massive public harm," Healey stated in her letter to Martin. Healey, who urged Gilead to adjust its pricing strategy, noted that the company has invoked the high cost and risk associated with research and development as a justification for its prices, but she said that Gilead quickly recouped its outlay to acquire Pharmasset by selling "$12.4B worth of HCV medication in the first year alone" after its deal. The AG, who said that Sovaldi costs $1,000 per pill in the U.S. but only $10 per pill in Egypt and about $4 per pill in India, contends that American taxpayers "have been footing the bill for Gilead's record profits." FREQUENT TARGET: The pricing of Gilead's hep C treatments have been the focus of significant criticism and political rhetoric in the past. In December, Senate Finance Committee Ranking Member Ron Wyden and senior committee member Chuck Grassley released the results of an 18-month investigation into the pricing and marketing of Sovaldi and Harvoni. The company "pursued a marketing strategy and final wholesale price of Sovaldi - $1,000 per pill, or $84,000 for a single course of treatment - that it believed would maximize revenue," and "fostering broad, affordable access was not a key consideration in the process of setting the wholesale prices," the senators wrote. Members of the Affordable Drug Pricing Task Force, who held a press conference last November to announce "meaningful action" to combat the "skyrocketing" costs of pharmaceuticals, specifically took aim at Sovaldi. During her campaigning efforts, presidential candidate Hillary Clinton has repeatedly decried the "outrageous" prices of specialty drugs. OTHERS TO WATCH: AbbVie (ABBV), Merck (MRK) and Johnson & Johnson (JNJ) also market or are at work on therapies for hepatitis C. PRICE ACTION: In morning trading, Gilead slid 2% to $90.35.
08:42 EDTYHOOIAC's Diller says would not buy Yahoo, Bloomberg reports
IAC (IAC) Chairman Barry Diller said Yahoo (YHOO) can be a standalone business, adding that he would not buy the company, according to Bloomberg. Diller said Yahoo is only worth buying at a "serious discount," according to Bloomberg.
07:04 EDTINTCThe Deal to hold a virtual roundtable
The "Internet of Things: Dealmaking" roundtable discussion about opportunities in IoT which is driving growth and M&A in sectors from telecom, software groups and device makers, will be held on January 27 at 1 pm. Webcast Link
January 26, 2016
18:00 EDTUALPAR Investment Partners reports 2.4% stake in United Continental
Subscribe for More Information
16:37 EDTUALAltimeter Capital reports 3.1% stake in United Continental, will continue talks
Subscribe for More Information
10:00 EDTRGCOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Amec Foster Wheeler (AMFW) downgraded to Hold from Buy at HSBC... CVR Refining (CVRR) downgraded to Sell from Neutral at Goldman... Cenovus Energy (CVE) downgraded to Neutral from Buy at UBS... Clean Harbors (CLH) downgraded to Underperform from Market Perform at Raymond James... Core Laboratories (CLB) downgraded to Reduce from Hold at HSBC... Delek US (DK) downgraded to Neutral from Buy at Goldman... Deutsche Post (DPSGY) downgraded to Underperform from Outperform at Credit Suisse... Disney (DIS) downgraded to Neutral on reduced ESPN forecasts at Atlantic Equities... Dorian LPG (LPG) downgraded to Market Perform from Outperform at Wells Fargo... Encana (ECA) downgraded to Neutral from Buy at UBS... Fortinet (FTNT) downgraded to Hold from Buy at Deutsche Bank... Fortune Brands (FBHS) downgraded to Neutral from Outperform at Credit Suisse... General Growth (GGP) downgraded to Equal Weight from Overweight at Barclays... Golden Ocean (GOGL) downgraded to Underweight from Neutral at JPMorgan... Grupo Mexico (GMBXF) downgraded to Neutral from Overweight at JPMorgan... Halliburton (HAL) downgraded to Hold from Buy at HSBC... Marketo (MKTO) downgraded to Underperform at BofA/Merrill... Navios Maritime (NM) downgraded to Neutral from Overweight at JPMorgan... NetSuite (N) downgraded to Underperform at BofA/Merrill... OM Asset Management (OMAM) downgraded to Equal Weight at Morgan Stanley... Paylocity (PCTY) downgraded to Underperform from Neutral at BofA/Merrill... Pennsylvania REIT (PEI) downgraded to Underweight from Equal Weight at Barclays... Pinnacle West (PNW) downgraded to Hold from Buy at Evercore ISI... Public Storage (PSA) downgraded to Equal Weight from Overweight at Barclays... Red Hat (RHT) downgraded to Neutral from Buy at BofA/Merrill... Regal Entertainment (RGC) downgraded on valuation at RBC Capital... Rouse Properties (RSE) downgraded to Equal Weight from Overweight at Barclays... Star Bulk Carriers (SBLK) downgraded to Neutral from Overweight at JPMorgan... Stratasys (SSYS) downgraded to Neutral from Overweight at JPMorgan... Subsea 7 (SUBCY) downgraded to Reduce from Hold at HSBC... US Ecology (ECOL) downgraded to Market Perform from Outperform at Raymond James... USG (USG) downgraded to Underperform from Neutral at Credit Suisse... Vornado (VNO) downgraded to Equal Weight from Overweight at Barclays... Weir Group (WEIGY) downgraded to Underperform from Hold at Jefferies.
08:23 EDTRGCRegal Entertainment downgraded on valuation at RBC Capital
Subscribe for More Information
06:10 EDTRGCRegal Entertainment downgraded to Sector Perform from Outperform at RBC Capital
Subscribe for More Information
05:15 EDTINTCStocks with implied volatility below IV index mean; AXP INTC
Stocks with implied volatility below IV index mean; American Express (AXP) 28, Intel (INTC) 27 according to iVolatility.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use